StreetAlpha.app
Home › Stocks › EPRX

Eupraxia Pharmaceuticals Inc. (EPRX)

Healthcare
$6.76
LAST CLOSE · NOV 2

Eupraxia Pharmaceuticals Inc. (EPRX) is a Healthcare stock tracked by StreetAlpha. It last closed at $6.76 on Nov 2. EPRX reports earnings on Tue, Nov 3, 2026. The average 12-month price target from 2 analysts is $14.00 (+107.1% from the last close), with a high of $17.00 and a low of $11.00. In the past 30 days there were 1 dark pool print totaling $358K, the largest $358K.

AI Auto Pilots
Is EPRX in one of our four AI portfolios? Sign in free to see

Key Stats

Fiscal 2025
Results
Revenue
$0
Net income
−$38.6M
Balance sheet
Cash & equivalents
$80.6M
At Dec 31
Shareholder equity
$82.0M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2023: $0$0FY2023FY2024: $0$0FY2024FY2025: $0$0FY2025

From EPRX's SEC filings, latest 40-F for the period ending Dec 31, 2025 (filed Mar 13). Per share figures are left out because the US listing can represent a different number of shares.

Next report
Nov 3
2026 · Time not announced
Consensus EPS forecast
-$0.26
 
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated EPRX in the past 90 days, not enough for a consensus
Average 12-month target
$14.00
▲ 107.1% upside

Based on 2 analysts who set a price target on EPRX in the past 90 days. The average target is $14.00, with a high of $17.00 and a low of $11.00, compared with the last close of $6.76.

Low $11.00Avg $14.00High $17.00
Blue marker: last close $6.76
Highest target$17.00
Average target$14.00
Lowest target$11.00
Latest rating changes
HC Wainwright & Co.Reiterated
Oct 1Buy$11
WedbushInitiated
Sep 24Buy$17
OppenheimerInitiated
Jun 26Buy$17
StifelInitiated
May 21Buy$25
DateFirmActionRatingPrice target
Oct 1HC Wainwright & Co.ReiteratedBuy$11
Sep 24WedbushInitiatedBuy$17
Jun 26OppenheimerInitiatedBuy$17
May 21StifelInitiatedBuy$25
Loading…

Technical Analysis

EPRX · as of the Nov 2 close · updated after every close
Turning down

The stock is 6% below its 20 day and 12% below its 50 day average. It is 8% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 42). The nearest support is the swing low (Aug 24) at $6.64, and the nearest resistance the Pivot at $6.78.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityNormal, 7.5%/day
Key levels
$9.3252 week high+37.9%
$7.5950 day average+12.3%
$7.30200 day average+8.0%
$7.1720 day average+6.1%
$7.04100 day average+4.1%
$6.91Pivot R1+2.2%
$6.83Swing high (Jul 22)+1.0%
$6.78Pivot+0.3%
$6.76Last close
$6.64Swing low (Aug 24)−1.8%
$6.63Pivot S1−1.9%
$5.2552 week low−22.3%
Indicators
RSI (14)42.40Middle of its rangeNeutral
MACD-0.18Below its signal lineBearish
Stochastic35.0Middle of its rangeNeutral
ADX (14)14.6No clear trend
Williams %R-77.1Oversold below −80, overbought above −20Neutral
CCI (20)-73.1Oversold below −100, overbought above 100Neutral
Rate of change−2.7%Change over 10 sessionsBearish
ATR (14)$0.51Typical daily range, 7.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for EPRX

What happened before

See how EPRX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

Earnings in less than a daySignals right before a report are less reliable. The report can override them.

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Whale Options Flow

90D

No whale options trades in EPRX in the last 90 days.

Loading…

Dark Pool

30D
Prints
1
Notional
$358K
Largest print
$358K
Loading…

EPRX Institutional Ownership

Hedge fund holdings →
Funds holding
68
+12 vs Q1 2026
Value held
$139.4M
24.8M shares
Buying vs selling
37 / 24
16 new · 6 sold out
Shares held
24.8M
+2.3M vs Q1 2026
Top holders · Q2 2026
3.6M shares$24K−39K
1.6M shares$10.9M+61K
1.4M shares$8.9M+15
4. Vivo Capital, LLCNo change
1.4M shares$8.9M0
1.3M shares$8.8M+1,548
1.2M shares$8.0M+670K
1.2M shares$7.9M0
1M shares$6.9M
867K shares$5.7M+176K
810K shares$5.4M−405K
#FundSharesValueChange
1Beutel, Goodman & Co Ltd.3.6M$24K−39KTrimmed
2Affinity Asset Advisors, LLC1.6M$10.9M+61KAdded
3Balyasny Asset Management L.P.1.4M$8.9M+15No change
4Vivo Capital, LLC1.4M$8.9M0No change
5Scotia Capital Inc.1.3M$8.8M+1,548Added
6PFM Health Sciences, LP1.2M$8.0M+670KAdded
7Great Point Partners LLC1.2M$7.9M0No change
8Jupiter Topco LLC1M$6.9M–
9Rubric Capital Management LP867K$5.7M+176KAdded
10Ikarian Capital, LLC810K$5.4M−405KTrimmed
Biggest buyers
Biggest sellers
Filed so far for Q3 2026 · 3 funds changed their position

From SEC Form 13F filings by funds managing over $100 million, as of Jun 30, 2026. Changes compare each fund with its own Q1 2026 filing. Filings come up to 45 days after the quarter ends. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether EPRX is in one of them and how their past EPRX trades turned out.

EPRX in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered EPRX in an article yet. Here's the latest on the wider market.